IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Pharma/fine chemicals roundup—20 May 2014

6:46 AM MDT | May 20, 2014 | Deepti Ramesh

AstraZeneca rejects Pfizer's latest offer AstraZeneca has rejected Pfizer's latest offer to buy AstraZeneca. Pfizer says its offer, which values AstraZeneca at £69 billion ($116 billion), is "final" and cannot be improved. "We have rejected Pfizer's final proposal because it is inadequate and would present significant risks for shareholders while also having serious consequences for the company, our employees, and the life sciences sector in the United Kingdom, Sweden, and the United States," says AstraZeneca chairman Leif Johansson...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


Comments (1) for Pharma/fine chemicals roundup—20 May 2014
Thanks for valuable information. Find world class chemical manufacturers and exporters in Pepagora @ http://www.pepagora.com/category/Chemicals
Posted by Pepagora on Wednesday, May 21, 2014 @ 03:58 AM

contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa